The Valley Desk

NCT02675231 · Interventional trial

A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

Overall registry status Completed

Phase 2

Conditions HER-2 Positive Breast Cancer, Hormone Receptor Positive Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov